References
Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS et al (2016) Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet 48:607–616. https://doi.org/10.1038/ng.3564
Cancer Genome Atlas N (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337. https://doi.org/10.1038/nature11252
Cancer Genome Atlas Research N (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068. https://doi.org/10.1038/nature07385
Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121
Cancer Genome Atlas Research Network. Electronic address aadhe, Cancer Genome Atlas Research N (2017) Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32(185–203):e113. https://doi.org/10.1016/j.ccell.2017.07.007
Chau LQ, Levy ML, Crawford JR (2019) Unusual KRAS missense mutation (p.E63K) in patient with juvenile pilocytic astrocytoma of the tectum. BMJ Case Rep. https://doi.org/10.1136/bcr-2018-228128
Chiang J, Harreld JH, Tinkle CL, Moreira DC, Li X, Acharya S et al (2019) A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Acta Neuropathol. https://doi.org/10.1007/s00401-019-02081-1
Chiang JC, Ellison DW (2017) Molecular pathology of paediatric central nervous system tumours. J Pathol 241:159–172. https://doi.org/10.1002/path.4813
Chiang JCH, Harreld JH, Tanaka R, Li X, Wen J, Zhang C et al (2019) Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis. Neuro Oncol 21:800–808. https://doi.org/10.1093/neuonc/noz037
Ellison DW, Hawkins C, Jones DTW, Onar-Thomas A, Pfister SM, Reifenberger G et al (2019) cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation. Acta Neuropathol 137:683–687. https://doi.org/10.1007/s00401-019-01987-0
Liu APY, Harreld JH, Jacola LM, Gero M, Acharya S, Ghazwani Y et al (2018) Tectal glioma as a distinct diagnostic entity: a comprehensive clinical, imaging, histologic and molecular analysis. Acta Neuropathol Commun 6:101. https://doi.org/10.1186/s40478-018-0602-5
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ et al (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527–532. https://doi.org/10.1038/370527a0
Funding
Funding was provided by American Lebanese Syrian Associated Charities.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chiang, J., Li, X., Liu, A.P.Y. et al. Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations. Acta Neuropathol 139, 601–602 (2020). https://doi.org/10.1007/s00401-019-02112-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-019-02112-x